Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
701.00    11.00 (1.59%)
Bid:
692.00
Ask:
710.00
Spread: 18.00 (2.601%)
Market Cap: £247.03m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

Share Buy-Back Programme

11 Jun 2024 07:01

RNS Number : 8774R
B.P. Marsh & Partners PLC
11 June 2024
 

11 June 2024

 

B.P. Marsh & Partners Plc

 

("B.P. Marsh" or the "Company")

 

Share Buy-Back Programme

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist venture capital investor in early stage financial services businesses, today announces the launch of a new share buy-back programme (the "Programme").

 

Further to the release of the Company's Annual Results, which reconfirmed the Company's intention to undertake on-market share buy-backs to return further capital to shareholders, the Board has today approved the Programme to repurchase ordinary shares of 10 pence each in the Company ("Ordinary Shares") for up to a maximum aggregate consideration of £1 million and subject to Ordinary Shares being available to purchase at a price representing a discount of at least 15% to the most recently announced diluted NAV per share prevailing at the time of repurchase.

 

The Programme will be carried out in accordance with the Company's general authority to purchase a maximum of 3,746,600 Ordinary Shares, granted by shareholders at the Company's Annual General Meeting which was held on 26 July 2023 (the "General Authority"), since when the Company has purchased 97,652 Ordinary Shares.

 

This General Authority expires at the Company's next Annual General Meeting to be held in July 2024 (the "2024 AGM"), at which the Company expects to seek shareholders' approval authorising another such general authority for a further 12 months, or, if earlier, at the close of business on 31 July 2025 (being, if approved, also a "General Authority"), subject to which the Programme will continue beyond the 2024 AGM in accordance with the renewed General Authority and the parameters set out above.

 

The purpose of the Programme is to reduce the Company's share capital and it will commence on the date of this announcement and continue until either the maximum pecuniary amount has been purchased under the Programme or, if earlier, the expiration of the relevant General Authority.

 

The Company has entered into an irrevocable commitment with Panmure Gordon (UK) Limited to conduct the Programme and repurchase Ordinary Shares on the Company's behalf and to make trading decisions under the Programme in accordance with certain pre-set parameters independently of the Company.

 

Share repurchases will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out. Under the Programme, the repurchased shares will be held in treasury at the Company's discretion for later reissue or cancellation. Shares held in treasury are not entitled to dividends and have no voting rights at the Company's general meetings.

 

The Programme will be conducted within the parameters of the Market Abuse Regulation 596/2014/EU (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and the delegated regulations made pursuant to it. The Company confirms that it currently has no unpublished price sensitive information.

 

The Company will announce any market purchase of Ordinary Shares pursuant to the Programme without delay.

 

For further information:

 

B.P. Marsh & Partners Plc

www.bpmarsh.co.uk

Brian Marsh OBE

+44 (0)20 7233 3112

Nominated Adviser & Broker

Panmure Gordon

Atholl Tweedie / Amrit Mahbubani / Ailsa MacMaster

+44 (0)20 7886 2500

Financial PR & Investor Relations

Tavistock

bpmarsh@tavistock.co.uk

Simon Hudson / Tim Pearson / Katie Hopkins

+44 (0)20 7920 3150

 

Notes to Editors:

B.P. Marsh's current portfolio contains fifteen companies. More detailed descriptions of the portfolio can be found at www.bpmarsh.co.uk.

 

Since formation over 30 years ago, the Company has assembled a management team with considerable experience both in the financial services sector and in managing private equity investments. Many of the directors have worked with each other in previous roles, and all have worked with each other for at least ten years.

- Ends -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFFSIRTIILIS
Date   Source Headline
24th Jun 20212:00 pmRNSShare Incentive Plan
8th Jun 20212:41 pmRNSDirector/PDMR Shareholding
8th Jun 20217:00 amRNSFinal Results
12th Apr 20214:07 pmRNSHolding(s) in Company
12th Apr 20214:06 pmRNSHolding(s) in Company
12th Apr 20214:05 pmRNSDirector/PDMR Shareholding
9th Apr 20215:26 pmRNSDirector/PDMR Shareholding
31st Mar 20213:00 pmRNSDirector/PDMR Shareholding
23rd Mar 20217:00 amRNSInvestee Company Update
4th Mar 20215:50 pmRNSDirector/PDMR Shareholding
9th Feb 20217:00 amRNSB.P. Marsh Trading Update
29th Jan 20215:11 pmRNSDirector/PDMR Shareholding
26th Jan 20217:00 amRNSInvestee Company Update: ATC Insurance Solutions
11th Jan 20217:00 amRNSInvestee Company Update - Nexus Underwriting
6th Jan 20215:39 pmRNSDirector/PDMR Shareholding
6th Jan 202112:04 pmRNSInvestee Company Update - XPT Group LLC
22nd Dec 20203:27 pmRNSDirector/PDMR Shareholding
14th Dec 20207:00 amRNSInvestee Company Update – Nexus Underwriting
19th Nov 20207:00 amRNSInvestee Company Update – Lilley Plummer Risks
27th Oct 202010:37 amRNSDirector/PDMR Shareholding
14th Oct 20203:54 pmRNSDirector/PDMR Shareholding
13th Oct 20207:00 amRNSInterim Results
23rd Sep 20203:01 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSTrading Update
4th Sep 20209:42 amRNSInvestee Company Update: LEBC
25th Aug 202010:36 amRNSInvestee Company Update
14th Aug 202011:41 amRNSDirector/PDMR Shareholding
13th Aug 202010:56 amRNSHolding(s) in Company
12th Aug 20204:14 pmRNSDirector/PDMR Shareholding
5th Aug 20207:00 amRNSFurther Progress at US Investee Company XPT Group
27th Jul 20204:13 pmRNSDirector/PDMR Shareholding
20th Jul 20205:05 pmRNSResult of AGM
13th Jul 20209:16 amRNSDubai International Financial Centre – EC3 Brokers
30th Jun 20203:21 pmRNSDirector/PDMR Shareholding
29th Jun 20207:00 amRNSInvestment – SAGE Program Underwriters
26th Jun 20203:04 pmRNSNotice of AGM
26th Jun 20209:28 amRNSDirector/PDMR Shareholding
23rd Jun 202012:27 pmRNSTotal Voting Rights
10th Jun 20202:05 pmRNSSecond Price Monitoring Extn
10th Jun 20202:00 pmRNSPrice Monitoring Extension
10th Jun 202011:36 amRNSDirector/PDMR Shareholding
9th Jun 20207:00 amRNSFinal Results
30th Apr 202012:41 pmRNSPortfolio Update
23rd Apr 202010:50 amRNSTotal Voting Rights
23rd Apr 20209:22 amRNSInvestee Company Acquisition
30th Mar 20205:52 pmRNSDirector/PDMR Shareholding
24th Mar 20204:05 pmRNSDirector/PDMR Shareholding
20th Mar 202010:47 amRNSDirector/PDMR Shareholding
13th Mar 20201:52 pmRNSDirector/PDMR Shareholding
5th Mar 20207:00 amRNSInvestee Company Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.